Key Highlights
- FutureFuel (NYSE:FF) was indicated at USD 3.60 pre-market on Tuesday, November 10, 2026, down 28.99% from a calculated prior close of USD 5.07 after results released on November 9.
- Third-quarter Revenue rose 361.3% to USD 104.7 million from USD 22.7 million, but the net loss was USD 8.4 million, or USD 0.19 per diluted share, against USD 9.2 million, or USD 0.21, a year earlier.
- Adjusted EBITDA was negative USD 4.9 million against negative USD 5.3 million, after about USD 4.3 million of drag from customer turnarounds, and the company expects about USD 7.0 million in the fourth quarter.
- Cash fell to USD 21.3 million from USD 34.3 million at June 30, 2026, with no borrowings on the USD 35 million revolver and 43,863,318 shares outstanding.
What Moved FutureFuel Pre-Market (-28.99%)
The FutureFuel (NYSE:FF) pre-market price of USD 3.60 compares with a calculated prior close of USD 5.07, a gap of about USD 1.47 per share. On 43,863,318 shares outstanding at September 30, 2026, calculated Market Value falls from about USD 222.4 million to about USD 157.9 million. The company released third-quarter results after the close on Monday, November 9, 2026 and scheduled its call for 11:00 a.m. ET on Tuesday, November 10. Revenue was USD 104.7 million, up USD 82.0 million. Biofuel revenue reached USD 87.8 million from USD 7.1 million, and chemical revenue was USD 16.9 million from USD 15.6 million, up 8.6%. Gross loss was USD 5.4 million against USD 6.5 million. Nine-month revenue was USD 215.4 million against USD 75.9 million, with a nine-month net loss of USD 17.6 million, or USD 0.40 per share.
Why FutureFuel Fell: Results, Segments and General Context
The catalyst identified is the third-quarter release, which showed another quarterly loss despite much higher revenue. Biofuel gross loss was USD 9.8 million against USD 2.4 million, while chemical Gross Profit was USD 4.4 million against a USD 4.1 million loss. Biofuel utilization rose to 83% from 56% in the second quarter, and chemicals utilization was 32% against 55% a year earlier. Operating Cash Flow was negative USD 10.3 million against negative USD 1.1 million, and Capital spending was USD 3.3 million. The release also guided to full-year capital spending of USD 25.8 million, including USD 10.2 million of customer-funded investment, a glycerin project worth USD 5.0 million to USD 10.0 million a year from 2027 and a new European chemicals customer with output due in the first quarter of 2027. The release does not link the drop to any single item. As general context, higher Volume with negative margins can disappoint investors who expect revenue growth to turn into profit.
Valuation, Liquidity and Risks for FutureFuel
Cash of USD 21.3 million equals about 13.5% of the calculated pre-market value of USD 157.9 million, and the USD 35 million revolver is undrawn. The company continues its quarterly cash dividend, though the release gives no per-share amount. Dividends payable were USD 0.6 million at quarter end. A 52-week range, average volume and pre-market volume could not be confirmed in published coverage, so none is given. The main risks are thin pre-market volume, wide spreads, reliance on the fourth-quarter EBITDA recovery that management expects, biofuel Margin swings and Reversal after the 9:30 a.m. ET open. A drop of this size does not imply further decline or recovery.
Where Things Stand
FutureFuel (NYSE:FF) is down 28.99% pre-market on Tuesday, November 10, 2026 after a third-quarter report with USD 104.7 million of revenue but a USD 8.4 million net loss and a USD 5.4 million gross loss. The USD 3.60 quote reflects thin trading and may not hold at the open. Management points to about USD 7.0 million of fourth-quarter adjusted EBITDA, which is the figure the market will test on the 11:00 a.m. ET call.




_11_16_2026_19_18_12_182061.jpg)

Please wait processing your request...